3160 Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Notices 

www.minorityhealth.hhs.gov. 

Information about ACMH activities can 

be found on the OMH website under the 

heading About OMH, Committees and 

Workgroups. 

DATES: The ACMH meeting will be held 

on Friday, January 29, 2021, from 1:30 

p.m. to 2:00 p.m. ET. If the Committee 

completes its work before 2:00 p.m., the 

meeting will end early. 

ADDRESSES: The meeting will be held 

virtually and will be accessible by 

webcast. 

FOR FURTHER INFORMATION CONTACT: 

Samuel Wu, Designated Federal Officer, 

Advisory Committee on Minority 

Health, Office of Minority Health, 

Department of Health and Human 

Services, Tower Building, 1101 Wootton 

Parkway, Suite 100, Rockville, 

Maryland 20852. Phone: 240–453–6173; 

email: OMH-ACMH@hhs.gov. 

SUPPLEMENTARY INFORMATION: In 

accordance with Public Law 105–392, 

the ACMH was established to provide 

advice to the Deputy Assistant Secretary 

for Minority Health on improving the 

health of each racial and ethnic 

minority group and on the development 

of goals and specific program activities 

of the OMH. 

The purpose of the January 2021 

ACMH meeting is to finalize 

recommendations for improving access 

to and utilization of clinical preventive 

services among racial and ethnic 

minority populations. The 

recommendations will be given to the 

Deputy Assistant Secretary for Minority 

Health to inform efforts for removing 

barriers to achieving health equity. 

The meeting is open to the public. 

Any individual who wishes to attend 

the meeting must register by sending an 

email to OMH-ACMH@hhs.gov by 5:00 

p.m. ET on January 28, 2021. Each 

registrant should provide name, 

affiliation, phone number, and email 

address. Registrants will receive 

webcast access information via email. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

contact OMH-ACMH@hhs.gov and 

reference this meeting. Requests for 

special accommodations should be 

made at least ten (10) business days 

prior to the meeting. 

Members of the public will have an 

opportunity to provide comments at the 

meeting. Public comments will be 

limited to two minutes per speaker 

during the time allotted. Individuals 

who would like to submit written 

statements should email OMH-ACMH@

hhs.gov at least five (5) business days 

prior to the meeting. 

Any members of the public who wish 

to distribute electronic or printed 

material(s) related to this meeting’s 

topic to ACMH members should email 

the Designated Federal Officer at OMHACMH@hhs.gov. The material should be 

received by the Designated Federal 

Officer at least five (5) business days 

prior to the meeting. 

Dated: January 11, 2021. 

Samuel Wu, 

Designated Federal Officer, Advisory 

Committee on Minority Health. 

[FR Doc. 2021–00660 Filed 1–13–21; 8:45 am] 

BILLING CODE 4150–29–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Interventions to Prevent Electronic Nicotine 

Delivery Systems (ENDS) Use Among 

Adolescents (R01—Clinical Trial Optional). 

Date: March 10, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Yvonne Owens Ferguson, 

Ph.D., Scientific Review Officer, Office of 

Extramural Policy and Review, Division of 

Extramural Research, National Institute on 

Drug Abuse, NIH, 301 North Stonestreet 

Avenue, MSC 6021, Bethesda, MD 20892, 

(301) 402–7371, yvonne.ferguson@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.277, Drug Abuse Scientist 

Development Award for Clinicians, Scientist 

Development Awards, and Research Scientist 

Awards; 93.278, Drug Abuse National 

Research Service Awards for Research 

Training; 93.279, Drug Abuse and Addiction 

Research Programs, National Institutes of 

Health, HHS) 

Dated: January 8, 2021. 

Tyeshia M. Roberson, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–00576 Filed 1–13–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Collection; 60-Day Comment 

Request Data and Specimen Hub 

(DASH) (Eunice Kennedy Shriver 

National Institute of Child Health and 

Human Development) 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995 to provide 

opportunity for public comment on 

proposed data collection projects, the 

Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development (NICHD), the National 

Institutes of Health will publish 

periodic summaries of propose projects 

to be submitted to the Office of 

Management and Budget (OMB) for 

review and approval. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 60 days of the date of this 

publication. 

FOR FURTHER INFORMATION CONTACT: To 

obtain a copy of the data collection 

plans and instruments, submit 

comments in writing, or request more 

information on the proposed project, 

contact: Regina Bures, Ph.D., Eunice 

Kennedy Shriver National Institute of 

Child Health and Human Development 

(NICHD), National Institutes of Health, 

6710B Rockledge Drive, Room 2160, 

Bethesda, MD 20817, or call non-tollfree number (301) 496–9485 or Email 

your request, including your address to: 

NICHD.DASH@mail.nih.gov. Formal 

requests for additional plans and 

instruments must be requested in 

writing. 

SUPPLEMENTARY INFORMATION: Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 requires: Written 

comments and/or suggestions from the 

public and affected agencies are invited 

to address one or more of the following 

points: (1) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

function of the agency, including 

whether the information will have 


khammond on DSKJM1Z7X2PROD with NOTICES